A Case of Isolated CNS Relapse in a CML Patient on Chronic Phase
Journal Title: International Blood Research & Reviews - Year 2015, Vol 4, Issue 2
Abstract
We report a patient who achieved hematologic response with Imatinib mesylate and is in chronic phase, but after several years developed neurologic symptoms and was eventually documented to have an isolated CNS relapse. The patient was treated with intrathecal chemotherapy to clear the spinal fluid of the leukemia cells. Imatinib mesylate (STI-571) is a potent and selective inhibitor of BCR-ABL tyrosine kinase and has emerged as a treatment of choice in chronic myeloid leukaemia. However because of poor penetration of the drug to the blood-brain barrier of the central nervous system (CNS), then the CNS acts as a sanctuary site for malignant cells.
Authors and Affiliations
Flordeluna Zapata-Mesina, Laurence Adlai B. Morillo, Ma Rosario Irene D. Castillo
Keywords
Related Articles
- EP ID EP242549
- DOI 10.9734/IBRR/2015/17731
- Views 140
- Downloads 0
Prevalence of Plasmodium and Salmonella Infections among Pregnant Women with Fever, Presented to Three Hospitals in Ogun and Lagos State, South-West Nigeria
Aims: The study was undertaken to establish prevalence of plasmodium and salmonella infections among pregnant women manifesting fever, presented to three hospitals in Lagos and Ogun state, Nigeria. To determine the rate...
Pattern, Determinants, and Costing Review of Send-out Tests in a Secondary Care Hospital Setting in Saudi Arabia
Background: The need for advanced laboratory tests, mostly performed at reference laboratories, increases over time. Officials have to choose between “send-out” testing or introducing such tests among their test menus, b...
Haematological Parameters of Adult and Paediatric Subjects with Sickle Cell Disease in Steady State, in Benin City, Nigeria
Background: Sickle cell disease (SCD) remains a major health burden in Sub-Saharan Africa and the management requires regular monitoring of the patients. The monitoring includes routine assessment of haematological param...
Thrombin Structural and Functional Determinants as Therapeutic Targets
Thrombin is the final serine protease generated during blood coagulation. This enzyme possesses a complex and fascinating structure composed not only by an active site but also by two positively charged patches, called a...
The Evaluation of Blood Requests for Transfusion and It’s Utilization in Four Iranian Hospitals
Background: Transfusion is one of the most important elements of healthcare. In order to save human lives, 85 million blood units are used in the world annually. Access to blood products is a common problem throughout th...